Cancer Cures News StoriesExcerpts of Key Cancer Cures News Stories in Major Media
Note: This comprehensive list of cancer cures news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
A report released this month by the Centers for Disease Control and Prevention and three prominent cancer research groups shows that cancer deaths in the United States are declining for men, women and children. New cancer diagnoses also declined for men from 2000 through 2009, the period the report examines, but remained stable for women and increased slightly for children. Here are the numbers: 1.8%: The percentage that cancer deaths decreased for both men and children from 2000 through 2009. For women, the decrease was 1.4 percent. 10%: The percentage that death rates decreased in the most common cancers in men. 15: The number of cancers most common in women that showed decreased death rates.
Note: For deeply revealing reports from reliable major media sources on promising cancer treatments and trends, click here.
Marijuana, already shown to reduce pain and nausea in cancer patients, may be promising as a cancer-fighting agent against some of the most aggressive forms of the disease. A growing body of early research shows a compound found in marijuana - one that does not produce the plant's psychotropic high - seems to have the ability to "turn off" the activity of a gene responsible for metastasis in breast and other types of cancers. Two scientists at San Francisco's California Pacific Medical Center Research Institute first released data five years ago that showed how this compound - called cannabidiol - reduced the aggressiveness of human breast cancer cells in the lab. "The preclinical trial data is very strong, and there's no toxicity. There's really a lot of research to move ahead with and to get people excited," said Sean McAllister, who along with scientist Pierre Desprez, has been studying the active molecules in marijuana - called cannabinoids - as potent inhibitors of metastatic disease for the past decade. Martin Lee, director of Project CBD, [a] group that works to raise awareness of the scientific promise of the compound, described the cannabidiol research as potent both as a medicine and a myth buster. "It debunks the idea that medicinal marijuana is really about people wanting to get stoned," said Lee, author of Smoke Signals, a book published last month about the medical and social history of marijuana. "Why do they want it when it doesn't even get them high?"
Note: For an educational, 45-minute documentary on this topic titled "What if Cannabis Cured Cancer?," click here. For an informative 15-minute documentary on the health benefits of juicing raw cannabis, click here. For deeply inspiring reports from reliable sources, click here.
Mounting evidence shows ‘cannabinoids’ in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. Peer-reviewed studies in several countries ... show that THC and other marijuana-derived compounds, known as “cannabinoids,” are effective not only for cancer-symptom management (nausea, pain, loss of appetite, fatigue), they also confer a direct antitumoral effect. A team of Spanish scientists led by Manuel Guzman conducted the first clinical trial assessing the antitumoral action of THC on human beings. THC treatment was associated with significantly reduced tumor cell proliferation in every test subject. Harvard University scientists reported that THC slows tumor growth in common lung cancer and “significantly reduces the ability of the cancer to spread.” What’s more ... THC selectively targets and destroys tumor cells while leaving healthy cells unscathed. Conventional chemotherapy drugs, by contrast, are highly toxic; they indiscriminately damage the brain and body. There is mounting evidence ... that cannabinoids “represent a new class of anticancer drugs that retard cancer growth, inhibit angiogenesis [the formation of new blood cells that feed a tumor] and the metastatic spreading of cancer cells.” Within the medical science community, the discovery that cannabinoids have anti-tumoral properties is increasingly recognized as a seminal advancement in cancer therapeutics.
Note: Yet treatment with cannabinoids continues to be largely illegal in the US. For an informative 15-minute documentary on the health benefits of juicing raw cannabis, click here. For deeply revealing reports from reliable major media sources on promising cancer-cure research, click here.
A single treatment to cure all cancers? Scientists may be one step closer. In a recent study, scientists reported that they successfully tested an antibody treatment that shrank human breast, ovary, colon, bladder, brain, liver and prostate tumors transplanted into mice. The antibody blocks a protein called CD47, which normally sits on the cell surface and issues a “don’t eat me” signal that prevents the body’s immune system from attacking it. About a decade ago, scientists at Stanford University School of Medicine, led by professor of pathology Irving Weissman, discovered that using an antibody to block CD47 cured some cases of leukemia and lymphoma in mice by allowing macrophages to seek and destroy the cancerous cells. In the new study, Weissman’s Stanford team showed that the CD47-blocking antibodies may also work against a number of other cancers. The researchers found that CD47 existed on nearly every cell, which suggests that the protein may be common to all cancers. Cancer cells expressed about three times more CD47 than healthy cells. “If the tumor was highly aggressive, the antibody also blocked metastasis. It’s becoming very clear that, in order for a cancer to survive in the body, it has to find some way to evade the cells of the innate immune system,” said Weissman in a statement. The antibody treatment didn’t work in all cases. Some mice injected with breast cancer cells from a human patient showed no changes after treatment. Yet in five mice with breast cancer, the antibody treatment cured them, with no signs of recurrence four months after treatment.
Note: With millions around the world dying of cancer every year, why aren't the most promising treatments being fast tracked? Why did it take 10 years form Weissman to reach this stage? Why isn't the very promising treatment of DCA, which is both cheap and incredibly promising, being given many millions to move rapidly forward? To read major media articles describing other potential cures not being adequately funded, click here. To understand why some treatments are suppressed, click here.
A few years ago researchers in California received widespread attention for showing that dogs can smell cancer on a human’s breath. With 99 percent accuracy the canines could detect if a person had lung or breast cancer, beating the best figures from standard laboratory tests. Subsequent studies confirmed the results. Technology startups have hustled to build digital devices that can mimic the dogs’ olfactory sense and reduce the need for biopsies and CAT scans. Metabolomx, a 12-person outfit in Mountain View, Calif., [is] bringing a cancer-sniffing device to market. The machine analyzes the breath and its volatile organic compounds, or VOCs—aerosolized molecules that, among other things, determine how something smells. Tumors produce their own VOCs, which pass into the bloodstream. The lungs create a bridge between the bloodstream and airways, so the breath exhaled by a patient will carry the VOC signatures of a tumor if one is present. “It may seem surprising, but it’s actually very straightforward,” says Paul Rhodes, the co-founder and chief executive officer at Metabolomx. Dr. Peter Mazzone, a lung cancer expert at the Cleveland Clinic, recently published results from a trial he ran with an early version of the Metabolomx machine. He studied 229 people and found that the machine could detect lung cancer more than 80 percent of the time. Just as intriguing, the machine outdid the dogs by distinguishing between different forms of lung cancer with about 85 percent accuracy, giving the doctor insight into whether a patient had an aggressive case.
Note: A machine has 80% accuracy in detecting this lethal disease, while sniffing dogs have 99% accuracy. Which would you rather have? For lots more from reliable sources on promising potential cancer-cure breakthroughs, click here.
Scientific discoveries of the greatest magnitude, including a discussion of the world’s most powerful microscope recently perfected after fourteen years effort by Dr. Royal Raymond Rife of San Diego, were described Friday evening to members of the medical profession ... at a dinner given by Dr. Milbank Johnson in honor of Dr. Rife and Dr. Arthur I. Kendall, head of the department of research bacteriology of the medical school of Northwestern, University, Chicago. Through the use of Dr. Rife's powerful microscope ... Dr. Kendall said he could see the typhoid Bacillus in the filterable or formally invisible stage. It is probably the first time the minute filterable organisms ever have been seen. Dr. Rife, who has been working alone in San Diego for more than fourteen years, told of his development of the superpowerful microscope and demonstrated it to the guests. The strongest microscopes now in use magnify between 2001 the 2500 times. Dr. Rife, by and ingenious rearrangement of lenses, applying an entirely new optical principle and by introducing double quartz prisms and powerful illuminating lights, has devised a microscope with a lowest magnification of 5000 diameters and a maximum working magnification of 17,000 diameters. The new microscope, scientists predict, also will prove a development of the first magnitude. Dr. Johnson's guests express themselves as delighted with the visual demonstration and heartily accorded to Dr. Rife and Dr. Kendall a foremost place in the world's rank of scientists.
Note: For a photo of this banquet and full text of the article, click here. For over a dozen exciting potential cancer cures reported in the major media, many of which have shown amazing results yet been suppressed or ignored, click here.
If the experimental results obtained at the Pasadena Hospital by Dr. Arthur I. Kendall, bacteriologist of Northwestern University, and Dr. Royal R. Rife of San Diego test true, man now has the knowledge and the weapon which will enable him to win the war against disease breeding germs. Having heard about a "wonder microscope," [Dr. Kendall] drove to San Diego and found Royal Raymond Rife and a new kind of microscope. This microscope has six quartz lenses, giving it a magnifying power eight times greater than the high powered-microscopes used by physicists. Dr. Milbank Johnson arranged for Dr. Kendall and Dr. Rife to get together at the Pasadena Hospital where ... the super microscope brought Kendall’s "seeds of life," distinctly within range of human vision. A bacillus or bacterium – a single cell organism – was seen to be made up of "granules." Each kind of granule ... has – under polarized light – a distinctive color of its own, thereby enabling bacteriologists to diagnose germ-diseases by the color of the germs. The bacilli studied are living ones, not corpses killed by stain. So extraordinary are these statements that scientists generally would regard them as visionary, or scientifically impossible, if they were not vouched for by such distinguished authorities. I witnessed a demonstration of the microscope [with] 250 scientists present. The impression prevailed that Dr. Rife ... has developed an instrument that may revolutionize laboratory methods and enable bacteriologists, like Dr. Kendall, to identify the germs that produce about 50 diseases whose cause are unknown, such as colds, influenza, infantile paralysis, measles, mumps, smallpox and ... to find ways and means of immunizing mankind against them.
With a giant, complex microscope invented and constructed in his laboratory workshop, Royal Raymond Rife, San Diego scientist, hopes to unlock mysteries of the bacteria world. Capable of magnifying an object 31,000 times compared with the 1600 to 1700 times of the standard microscope, Rife's instrument had disclosed to his eye minute deadly enemies of the human body which never before, he says, have been seen. Viruses ... have been observed in perfect clarity through his microscope, Rife asserts. One such virus ... has been found in cases of cancer, leading Rife to the belief that intensive future research may show its possible relationship to the cause of this disease. Rife has delved into the mysteries of a wide range of subjects, from ballistics, internal combustion engines and optics to microphotography. But of all of his scientific marvels, the intricately built microscope, culmination of two decades development, seems the greatest. Standing two feet high and weighing 200 pounds, it contains 5682 individual parts. Unlike the standard microscope, the image does not pass through free air in a hollow tube, with the resultant distortion. It is conveyed, instead, zigzag fashion through quartz blocks and prisms along the optical path. For organisms too small to be stained, an ingenious illuminating system is used. This system utilizes Rife's theory that organisms respond to certain wavelengths, a theory he carries to finality by bombarding disease germs with radio waves which are "tuned" to those of the minute man-killers. And the virus he says occurs in cancer has, Rife insists, disintegrated under such radio waves.
Note: As the above link requires payment, you can read the full text of this article free at this link. For over a dozen exciting potential cancer cures reported in the major media, many of which have shown amazing results yet been suppressed or ignored, click here.
Germs that cause cancer have been discovered and with a new high-frequency radio "ray." They have been killed in human patients who then recovered, according to assertions made yesterday at the California State Homeopathic Medical society’s convention. The new progress in combating malignant cancer is said to have been made possible by an ultra microscope that magnifies 31,000 times and by a ray that kills micro-organisms in humans. Both the microscope and the Ray were developed by Royal Raymond Rife of San Diego. Rife was to have announced his discoveries before the British Medical Society, but made the announcement locally because of the war. Dr. Arthur W. Yale of San Diego reported that with the aid of the Rife Ray he has succeeded in curing a number of cases of malignant cancer in which patients had been told they had only a limited time in which to live. The physician [said that] "for 17 years Mr. Rife experimented with vibratory waves of all frequencies, and he has now succeeded in finding a rate that will kill the different invading organisms of the body. Radio waves, which with their harmonics range from 10 meters to 20,000 meters, are projected through a tube filled with helium gas. I have witnessed the disappearance of every malignant growth when the patient has remained under treatment." Dr. Yale then reported case histories of patients treated. Mr. Rife alluded to the fact that the medical profession has not yet accepted his findings. “My work may not be accepted during my lifetime," he said, "but ... I know it ultimately will be recognized.
Note: As the above link requires payment, you can read the full text of this article free at this link. For an abundance of powerful, verifiable information on this amazing man and how his cancer cure was ruthlessly suppressed by the medical establishment, click here.
Born to Chinese immigrants, 17-year-old Angela Zhang of Cupertino, California is a typical American teenager. She's really into shoes and is just learning how to drive. But there is one thing that separates her from every other student at Monta Vista High School, something she first shared with her chemistry teacher, Kavita Gupta. It's a research paper Angela wrote in her spare time -- and it is advanced, to say the least. "Cure for cancer -- a high school student," said Gupta. "It's just so mind-boggling. I just cannot even begin to comprehend how she even thought about it or did this." When she was a freshman, she started reading doctorate level papers on bio-engineering. By sophomore year she'd talked her way into the lab at Stanford, and by junior year was doing her own research. Angela's idea was to mix cancer medicine in a polymer that would attach to nanoparticles -- nanoparticles that would then attach to cancer cells and show up on an MRI, so doctors could see exactly where the tumors are. Then she thought [of aiming] an infrared light at the tumors to melt the polymer and release the medicine, thus killing the cancer cells while leaving healthy cells completely unharmed. It'll take years to know if it works in humans -- but in mice -- the tumors almost completely disappeared. Angela recently entered her project in the national Siemens science contest. It was no contest. She got a check for $100,000.
Note: If this technique has already melted tumors in mice, why is CBS saying it will take years to know if it works in humans? Why wouldn't millions be poured in to fast track research on this exciting technology?
From the island nation known for the quality of its cigars comes some pretty big news today: Cuban medical authorities have released the first therapeutic vaccine for lung cancer. CimaVax-EGF is the result of a 25-year research project at Havana’s Center for Molecular Immunology, and it could make a life or death difference for those facing late-stage lung cancers. CimaVax-EGF isn’t a vaccine in the preventative sense--that is, it doesn’t prevent lung cancer from taking hold in new patients. It’s based on a protein related to uncontrolled cell proliferation--that is, it doesn’t prevent cancer from existing in the first place but attacks the mechanism by which it does harm. As such it can turn aggressive later-stage lung cancer into a manageable chronic disease by creating antibodies that do battle with the proteins that cause uncontrolled cell proliferation, researchers say. Chemotherapy and radiotherapy are still recommended as a primary means of destroying cancerous tissue, but for those showing no improvement the new vaccine could be a literal lifesaver. The vaccine has already been tested in 1,000 patients in Cuba and is being distributed at hospitals there free of charge. That’s a big deal for a country where smoking is part of the national culture and a leading cause of death. If it proves as successful as researchers say it is, it should give those suffering from lung cancer reason to celebrate--just not with a Cohiba.
Note: For lots more on important health issues from reliable sources, click here.
An engineered virus, injected into the blood, can selectively target cancer cells throughout the body in what researchers have labelled a medical first. The virus attacked only tumours, leaving the healthy tissue alone, in a small trial on 23 patients, according to the journal Nature. Researchers said the findings could one day "truly transform" therapies. Cancer specialists said using viruses showed "real promise". Using viruses to attack cancers is not a new concept, but they have needed to be injected directly into tumours in order to evade the immune system. The virus, named JX-594 ... was injected at different doses into the blood of 23 patients with cancers which had spread to multiple organs in the body. Prof John Bell, lead researcher and from the University of Ottawa, said: "We are very excited because this is the first time in medical history that a viral therapy has been shown to consistently and selectively replicate in cancer tissue after intravenous infusion in humans. Intravenous delivery is crucial for cancer treatment because it allows us to target tumours throughout the body as opposed to just those that we can directly inject."
Note: With millions of people dying of cancer every year, why isn't this being fast tracked like the AIDS drugs were? For exciting information from reliable sources on promising new cancer cure possibilities, click here.
Doctors have treated only three leukemia patients, but the sensational results from a single shot could be one of the most significant advances in cancer research in decades. Doctors at the University of Pennsylvania say the treatment made the most common type of leukemia completely disappear in two of the patients and reduced it by 70 percent in the third. In each of the patients as much as five pounds of cancerous tissue completely melted away in a few weeks, and a year later it is still gone. The results of the preliminary test “exceeded our wildest expectations,” says immunologist Dr. Carl June a member of the Abramson Cancer Center's research team. Chemotherapy and radiation can hold this form of leukemia at bay for years, but until now the only cure has been a bone marrow transplant. A bone marrow transplant requires a suitable match, works only about half the time, and often brings on severe, life-threatening side effects such as pain and infection. So why has this remarkable treatment been tried so far on only three patients? Both the National Cancer Institute and several pharmaceutical companies declined to pay for the research. Neither applicants nor funders discuss the reasons an application is turned down.
Note: For key reports from reliable sources on hopeful new cancer treatments, click here.
There is an epidemic of cancer today. One in three Americans will be diagnosed with cancer, often before the age of 65. Since 1940, we have seen in Western societies a marked and rapid increase in common types of cancer. In fact, cancer in children and adolescents has been rising by 1 to 1.5 percent a year since the 1960's. And these are cancers for which there is no screening. For most common cancers - prostate, breast, colon, lung - rates are much higher in the West than in Asian countries. Yet Asians who emigrate to the United States catch up with the rates of Americans within one or two generations. While in Asia, Asians are protected not by their genes, but by their lifestyle. We continue to invest 97 percent of our cancer research funds in better treatments and early detection. Only 3 percent is invested in tackling causes. The World Cancer Research Fund published a report in 2007 concluding that a majority of cancer cases in Western societies could be avoided with life-style measures: 40 percent from changes in diet and physical activity (more vegetables and fruits, less sugar, less red meat, regular walking or the equivalent activity 30 minutes six times per week), 30 percent from smoking cessation, and about 10 percent from reduced alcohol consumption. We now even have data about how specific foods such as broccoli and cabbages, garlic and onions, green tea or the spice turmeric directly help kill cancer cells and reduce the growth of new blood vessels they need to develop into tumors.
Note: The author of this article, Dr. David Servan-Schreiber, is a clinical professor of psychiatry at the University of Pittsburgh and a founding board member of Doctors Without Borders, USA, and author of Anticancer - A new way of life. For an excellent, inspiring 10-minute video interview with this doctor, click here.
To call what the Hyde family has been through a "parent's worst nightmare" sounds like a horrible cliche. But, it's hard to imagine what else you could call it. Their two-year-old son Cash was diagnosed last year with a stage 4 brain tumor; he nearly died more times than they can count. He was miserable from the chemotherapy coursing through his body until his dad made a controversial decision to give cannabis to his young son. The doctors had no answers, so Mike found his own. It was relief for Cashy in the form of cannabis oil. It's illegal to possess without authorization from a medical professional. It's something doctors wouldn't even discuss. Mike got authorization to give Cashy the oil and, without telling them why, told the doctors to wean Cashy off the anti-nausea cocktail. Inserted through Cashy's feeding tube, a tiny amount of oil replaced all those drugs. The result, Mike said, was almost immediate. Mike Hyde, though, doesn't care about the controversy or the political battle over this drug. He cares that his son survived and is convinced not only did the cannabis help Cashy feel better, it prevented long-term damage to his organs. For Mike, the proof is in his vibrant two-year old boy. "It's very controversial, it's very scary. But, there's nothing more scary than losing your child." A few weeks ago, Cashy was back in Salt Lake City for scans and found out he's cancer-free.
Cancer is not one disease. It is many. Yet oncologists have long used the same blunt weapons to fight different types of cancer: cut the tumour out, zap it with radiation or blast it with chemotherapy that kills good cells as well as bad ones. New cancer drugs are changing this. Scientists are now attacking specific mutations that drive specific forms of cancer. A breakthrough came more than a decade ago when Genentech, a Californian biotech firm, launched a drug that attacks breast-cancer cells with too much of a certain protein, HER2. In 2001 Novartis, a Swiss drugmaker, won approval for Gleevec, which treats chronic myeloid leukaemia by attacking another abnormal protein. Other drugs take different tacks. Avastin, introduced in America in 2004 by Genentech, starves tumours by striking the blood vessels that feed them. These new drugs sell well. Last year Gleevec grossed $4.3 billion. Roche’s Herceptin (the HER2 drug) and Avastin did even better: $6 billion and $7.4 billion respectively. The snag, from society’s point of view, is that all these drugs are horribly expensive. Last year biotech drugs accounted for 70% of the increase in pharmaceutical costs in America, according to Medco, a drug-plan manager. Cancer plays a huge role in raising costs.
Eric Merola's "Burzynski" charts how a Texas medical doctor and biochemist developed Antineoplastons, genetic-targeted medicines, and with them began to treat a wide range of cancers, including difficult-to-treat brain malignancies, with remarkable and continuing success only to bring down the full force of the medical establishment, which has laid assault to him in the most stupefying, devious and costly manner. Stanislaw Burzynski, a Polish immigrant ... eventually won a 14-year struggle – during which he found himself threatened with life imprisonment and astronomical fines for fraud and other violations – to obtain FDA-approved clinical trials of his Antineoplastons, an ordeal that cost Burzynski $2.2 million in legal expenses and the FDA $60 million in taxpayers' money. The film makes the case that big pharmacy holds the FDA in its thrall. Burzynski's Antineoplastons, with their high success rate and lack of side effects, pose a significant threat to the trillion-dollar industry of treating cancer with the traditional methods of surgery, radiation and chemotherapy.
Note: The Los Angeles Times now requires payment to view this article at this link. For the Burzynski clinic website, click here. You can watch part or all of this revealing movie at this link. For another powerful documentary featuring a variety of potential cancer cures that have been suppressed, click here. For excerpts from numerous major media articles with potential cancer cures that are being suppressed, click here.
We could make faster progress against cancer by changing the way drugs are developed. In the current system, if a promising compound can’t be patented, it is highly unlikely ever to make it to market — no matter how well it performs in the laboratory. The development of new cancer drugs is crippled as a result. The reason for this problem is that bringing a new drug to market is extremely expensive. In 2001, the estimated cost was $802 million; today it is approximately $1 billion. To ensure a healthy return on such staggering investments, drug companies seek to formulate new drugs in a way that guarantees watertight patents. In the meantime, cancer patients miss out on treatments that may be highly effective and less expensive to boot. In 2004, Johns Hopkins researchers discovered that an off-the-shelf compound called 3-bromopyruvate could arrest the growth of liver cancer in rats. The results were dramatic; moreover, the investigators estimated that the cost to treat patients would be around 70 cents per day. Yet, three years later, no major drug company has shown interest in developing this drug. The hormone melatonin, sold as an inexpensive food supplement in the United States, has repeatedly been shown to slow the growth of various cancers when used in conjunction with conventional treatments. Early this year, another readily available industrial chemical, dichloroacetate, was found by researchers at the University of Alberta to shrink tumors in laboratory animals by up to 75 percent. However ... dichloroacetate is not patentable, and the lead researcher is concerned that it may be difficult to find funding from private investors to test the chemical. Potential anticancer drugs should be judged on their scientific merit, not on their patentability.
Note: To explore several cancer cures which have shown dramatic potential, yet are not being studied for lack of funds due to inability to patent the process, click here. Why are these very promising treatments not being fast-tracked as the expensive AIDS drugs were? For a top MD's revealing comments on this, click here. And for why the media won't feature these promising cancer treatments in headlines, click here.
By now, you likely know David Seidler, who won an Oscar on Sunday for best original screenplay for "The King's Speech," was a stutterer just like King George VI, whose battle with the speech disorder is portrayed in the film. What you might not know is that Seidler, 73, suffered from cancer, just like the king did. But unlike his majesty, Seidler survived the cancer, and he says he did so because he used the same vivid imagination he employed to write his award-winning script. Seidler says he visualized his cancer away. "I know it sounds awfully Southern California and woo-woo," he admits when he describes the visualization techniques he used when his bladder cancer was diagnosed nearly six years ago. "But that's what happened." Seidler says when he found out his cancer had returned, he visualized a "lovely, clean healthy bladder" for two weeks, and the cancer disappeared. He's been cancer-free for more than five years. Whether you can imagine away cancer, or any other disease, has been hotly debated for years. One camp of doctors will tell you that they've seen patients do it, and that a whole host of studies supports the mind-body connection. Other doctors, just as well-respected, will tell you the notion is preposterous, and there's not a single study to prove it really works. Seidler isn't concerned about studies. He says all he knows is that for him, visualization worked.
Note: The article goes on to quote a couple doctors who explain how chemically hope and visualization can cause the changes in the body's chemistry which could lead to spontaneous remission in cancer. For other fascinating major media articles listing potential cancer cures, click here.
Is the common nature of cancer worldwide purely a man-made phenomenon? That is what some researchers now suggest. Scientists have only found one case of the disease in investigations of hundreds of Egyptian mummies, researcher Rosalie David at the University of Manchester in England said in a statement. The rarity of cancer in mummies suggests it was scarce in antiquity, and "that cancer-causing factors are limited to societies affected by modern industrialization," researcher Michael Zimmerman at Villanova University in Pennsylvania said in a statement. "In an ancient society lacking surgical intervention, evidence of cancer should remain in all cases." Zimmerman was the first to diagnose cancer in an Egyptian mummy by analyzing its tissues on a microscopic level, identifying rectal cancer in an unnamed mummy who had lived in the Dakhleh Oasis during the Ptolemaic period 1,600 to 1,800 years ago. As they analyzed ancient literature, they did not find descriptions of operations for breast and other cancers until the 17th century, and the first reports in the scientific literature of distinctive tumors have only occurred in the past 200 years, such as scrotal cancer in chimney sweepers in 1775, nasal cancer in snuff users in 1761 and Hodgkin's disease in 1832. David and Zimmerman therefore argue that cancer nowadays is largely caused by man-made environmental factors such as pollution and diet. They detailed their findings in the October issue of the journal Nature Reviews Cancer.
Note: For key reports from reliable sources on important health issues, click here.
Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.